Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 6 pp 4866—4878

MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer

class="figure-viewer-img"

Figure 2. ROC analysis demonstrating that serum miR-519d levels can distinguish NSCLC patients from healthy controls.